Yellow phosphorous poisoning and its treatment with exchange blood transfusion

Exchange transfusion in yellow phosphorous (YP) poisoning

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/02/004423

Enrollment

Registered

2014-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children with yellow phosphorous poisoning ,who come to the department of pediatrics.JIPMER

Interventions

Intervention1: Exchange transfusion: Children with Yellowphosphorous poisoning will be treated in our Pediatric intensive care unit and ingesting more than 1mg/kg body weight of YP will have exchange

Eligibility

Inclusion criteria

Inclusion criteria: Children with Yellowphosphorous poisoning will be treated in our Pediatric intensive care unit and ingesting more than 1mg/kg body weight of YP will have exchange transfusion.

Exclusion criteria

Exclusion criteria: Those who donot give consent will be excluded from this study.

Design outcomes

Primary

Measure	Time frame
Death due to to YP poisoningTimepoint: Death due to to YP poisoning	—

Secondary

Measure	Time frame
co morbidity like hepatic ,renal dysfunction associated with YP poisoningTimepoint: 6 days from the date of poison ingestion	—

Countries

India

Contacts

Public ContactDr Niranjan Biswal

JIPMER.Pondicherry

drnbiswal@yahoo.com9442528402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026